FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+8.86%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$141M
AUM Growth
+$141M
(+20%)
Cap. Flow
+$20.8M
Cap. Flow
% of AUM
14.7%
Top 10 Holdings %
Top 10 Hldgs %
39.69%
Holding
74
New
8
Increased
33
Reduced
5
Closed
4
Top Buys
| 1 |
TLGT
Teligent, Inc
TLGT
|
$6.41M |
| 2 |
Harvard Bioscience
HBIO
|
$4.56M |
| 3 |
ENZ
Enzo Biochem, Inc.
ENZ
|
$4.38M |
| 4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$3.52M |
| 5 |
Bio-Techne
TECH
|
$2.9M |
Top Sells
| 1 |
TEAR
TearLab Corporation
TEAR
|
$4.75M |
| 2 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
$3.31M |
| 3 |
ACCL
ACCELRYS INC
ACCL
|
$2.99M |
| 4 |
AtriCure
ATRC
|
$2.62M |
| 5 |
ARTC
ARTHROCARE CORP
ARTC
|
$1.77M |
Sector Composition
| 1 | Healthcare | 85.86% |
| 2 | Consumer Staples | 2.17% |
| 3 | Financials | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
| $2.24M | 1.59% |
+175,655
| New | +$2.24M |
|
|
ABCO
27
DELISTED
Advisory Board Co/The
ABCO
| $2.14M | 1.52% |
33,327
+4,777
| +17% | +$307K |
|
28
HealthStream
HSTM
$832M
| $1.87M | 1.32% |
69,891
+10,064
| +17% | +$269K |
|
29
LeMaitre Vascular
LMAT
$2.14B
| $1.8M | 1.28% |
223,409
+34,003
| +18% | +$274K |
|
30
Align Technology
ALGN
$9.59B
| $1.62M | 1.15% |
31,346
+4,236
| +16% | +$219K |
|
|
SGNT
31
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.52M | 1.07% |
64,856
+9,237
| +17% | +$216K |
|
32
Cytokinetics
CYTK
$5.98B
| $1.46M | 1.03% |
153,338
+22,887
| +18% | +$217K |
|
33
Masimo
MASI
$7.43B
| $1.42M | 1% |
51,865
+7,214
| +16% | +$197K |
|
|
GNMK
34
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.4M | 0.99% |
141,124
+22,786
| +19% | +$227K |
|
35
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.28M | 0.9% |
18,689
+2,472
| +15% | +$169K |
|
|
OREX
36
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.27M | 0.9% |
195,359
+24,555
| +14% | +$160K |
|
|
COV
37
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $1.25M | 0.89% |
17,013
+2,434
| +17% | +$179K |
|
|
ELGX
38
DELISTED
Endologix Inc
ELGX
| $1.13M | 0.8% |
87,758
+12,020
| +16% | +$155K |
|
39
Vertex Pharmaceuticals
VRTX
$102B
| $1.06M | 0.75% |
14,990
+1,971
| +15% | +$139K |
|
40
AngioDynamics
ANGO
$432M
| $1.01M | 0.72% |
64,260
+7,397
| +13% | +$116K |
|
|
HTWR
41
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $986K | 0.7% |
10,516
+1,539
| +17% | +$144K |
|
|
PETX
42
DELISTED
Aratana Therapeutics, Inc.
PETX
| $914K | 0.65% |
49,263
-5,026
| -9% | -$93.3K |
|
|
THOR
43
DELISTED
THORATEC CORPORATION
THOR
| $867K | 0.61% |
24,204
+2,698
| +13% | +$96.6K |
|
|
SURG
44
DELISTED
SYNERGETICS USA, INC.
SURG
| $832K | 0.59% |
272,851
+37,852
| +16% | +$115K |
|
|
FRX
45
DELISTED
FOREST LABORATORIES INC
FRX
| $704K | 0.5% |
7,635
| – | – |
|
|
VVUS
46
DELISTED
Vivus Inc
VVUS
| $693K | 0.49% |
116,696
+19,031
| +19% | +$113K |
|
|
ENDP
47
DELISTED
Endo International plc
ENDP
| $626K | 0.44% |
9,125
| – | – |
|
48
Novartis
NVS
$248B
| $516K | 0.37% |
6,070
| – | – |
|
49
Viatris
VTRS
$12.3B
| $477K | 0.34% |
9,775
| – | – |
|
50
Bristol-Myers Squibb
BMY
$96.7B
| $431K | 0.31% |
8,290
| – | – |
|